Harbour Investments’s Acceleron Pharma XLRN Stock Holding History

Harbour Investments’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-213	Closed	-$37K	–	4021
2021 Q3	$37K	Buy	213 +6	+3%	+$785	﹤0.01%	1962
2021 Q2	$26K	Hold	207	–	–	﹤0.01%	2203
2021 Q1	$28K	Buy	+207	New	+$26.7K	﹤0.01%	2027

Harbour Investments's XLRN Position: Q4 2021 in Review

Harbour Investments sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 213 shares — an estimated $37K sold.

Harbour Investments first reported a position in XLRN in Q1 2021 and held it in 3 quarters. The position peaked at $37K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Harbour Investments reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Harbour Investments sold 213 Acceleron Pharma shares in Q4 2021, an estimated $37K.
Harbour Investments first reported a position in Acceleron Pharma in Q1 2021 and held it in 3 quarters.
Harbour Investments's Acceleron Pharma position peaked at $37K in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Harbour Investments's 13F filing for Q4 2021, filed 16 Feb 2022.